Treating Drug Abusers Effectively

The 11 original articles that comprise this book are the result of a collaboration between researchers and policymakers that was organized by the National Institute on Drug Abuse and the Milbank Memorial Fund. These articles assess research-based knowledge about effective treatment in order to provide guidance to policymakers.

Table of Contents:
Notes on Contributors. Foreword: Samuel L. Milbank and Carl H. Pforzheimer III. Acknowledgements. Introduction: Joel A. Egertson, Daniel M. Fox and Alan I. Leshner. Part I: Research Findings on Drug-Abuse Treatment: 1. Evaluating the Effectiveness of Addiction Treatments: Reasonable Expectations, Appropriate Comparisons: A. Thomas McLellan. 2. Effectiveness of Drug-Abuse Treatment: A Review of Research from Field Settings: D. Dwayne Simpson. 3. Need and Access to Drug-Abuse Treatment: Constance Horgan. 4. Staffing Patterns and Services for the War on Drugs: Barry S. Brown. 5. What We Know and What We Actually Do: Best Practices and Their Prevalence in Substance-Abuse Treatment: Richard H. Price. Part II: Financing Drug-Abuse Treatment: 6. Drug-Abuse Treatment Costs: An Interpretive Essay: Allen C. Goodman, Janet R. Harkin and Eleanor Nishiura. 7. Cost Benefit and Cost-Effectiveness Analysis: Issues in the Evaluation of the Treatment of Illicit Drug Abuse: Jody L. Sindelat and Willard G. Manning, Jr. 8. Some Economics of Performance-Based Contracting for Substance-Abuse Services: Margaret Commons and Thomas G. McGuire. Part III: Special Issues in Drug-Abuse Treatment: 9. The Development of Effective Drug-Abuse Services for Youth: Scott W. Henggeler. 10. Casualties of the Drug War: An Equality-Based Argument for Drug Treatment: David Cole and Barry Littman. 11. Linking Substance-Abuse Treatment and Primary Health Care: Thomas D'Aunno. Index.

About the Author :
Joel A. Egertson is senior advisor to the director of the Medications Development Division at the National Institute on Drug Abuse (NIDA). He has served in numerous positions in the criminal justice, and alcohol and drug fields. He was a probation officer at Hennepin County Court Services, director of the methadone treatment program at Mount Sinai Hospital in Minneapolis, Minnesota, executive director of the Minnesota State Alcohol and Drug Abuse Authority, manager of field services at the National Center for Alcohol Education (University Research Corporation), a deputy division director at The National Institute on Alcohol Abuse and Alcoholism, and chief of the legislative branch at NIDA before assuming his present position. Daniel M. Fox is president of the Milbank Memorial Fund. His most recent book, Power and Illness: The Failure of American Health Policy (1993), was released in paperback in 1995. Alan I. Leshner is director of the National Institute on Drug Abuse, a component of the National Institutes of Health charged with leading the nation's efforts to bring the power of science to bear on drug abuse and addiction. Dr. Leshner received his PhD in physiological psychology from Rutgers University, was a professor of psychology at Bucknell University, held a variety of senior level positions at the National Science Foundation, and served as deputy director and acting director of the National Institute of Mental Health. He has been elected a fellow of many professional societies, and has received numerous awards from both professional and lay groups for his national leadership in science, mental illness and mental health, and substance abuse and addiction.